Filters: Author is Isakov, V  [Clear All Filters]
Isakov V, Chulanov V, Abdurakhmanov D, et al. Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden. Infect Dis (Lond). 2019;51(2):131-139. doi:10.1080/23744235.2018.1535186.
Isakov V, Gankina N, Morozov V, et al. Ledipasvir-sofosbuvir for 8 weeks in non-cirrhotic patients with previously untreated genotype 1 HCV Infection ± HIV-1 co-infection. Clin Drug Investig. 2018;38(3):239-247. doi:10.1007/s40261-017-0606-0.